Dandelion is creating the world’s first Generative Neuromodulation™ platform to treat the brain.
“Enthusiastic on the potential implications of this innovative technology.” National Institutes of Health
New Paradigm
Most treatments for brain disorders targeting neurochemistry have broad often deleterious effects on neurofunction. At Dandelion, we are developing a platform to program network dynamics in the brain.
News
Is there a programming language for the brain?
Let’s find out together.
Join our mission by emailing us at careers@dandelion.science
Our offices
USA
Dandelion Science Corp
75 State Street, Suite 100
Boston, MA, 02109
USA
Switzerland
Dandelion Science Sàrl
Chemin des Mines 9
CH-1202 Geneva
Switzerland